43
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Method for assessing coating uniformity of angioplasty balloons coated with poly(lactic-co-glycolic acid) nanoparticles loaded with quercetin

, , , &

References

  • Anderson, J. A., S. Lamichhane, T. Remund, P. Kelly, and G. Mani. 2016. Preparation, characterization, in vitro drug release, and cellular interactions of tailored paclitaxel releasing polyethylene oxide films for drug-coated balloons. Acta biomaterialia 29:333–51. doi:10.1016/j.actbio.2015.09.036.
  • Byrne, R. A., M. Joner, F. Alfonso, and A. Kastrati. 2014. Drug-coated balloon therapy in coronary and peripheral artery disease. Nature Reviews. Cardiology 11 (1):13–23. doi:10.1038/nrcardio.2013.165.
  • Craciun, I., C. E. Astete, D. Boldor, M. H. Jennings, J. D. Gorman, C. M. Sabliov, and T. R. Dugas. 2022. Nanoparticle coatings for controlled release of quercetin from an angioplasty balloon. PloS One 17 (8):e0268307. doi:10.1371/journal.pone.0268307.
  • Dagher, O., P. Mury, N. Thorin-Trescases, P. E. Noly, E. Thorin, and M. Carrier. 2021. Therapeutic potential of quercetin to alleviate endothelial dysfunction in age-related cardiovascular diseases. Frontiers in Cardiovascular Medicine 8:658400. doi:10.3389/fcvm.2021.658400.
  • Doshi, M., P. Sojitra, D. Shah, S. Dani, and A. Abizaid. 2019. Technical insights on drug-coated balloons II. In Drug-coated balloons: Applications in interventional cardiology, ed. B. Cortese, 45–57. Cham: Springer International Publishing.
  • Dugas, T. R., G. Brewer, M. Longwell, T. Fradella, J. Braun, C. E. Astete, M. H. Jennings, and C. M. Sabliov. 2019. Nanoentrapped polyphenol coating for sustained drug release from a balloon catheter. Journal of Biomedical Materials Research. Part B, Applied Biomaterials 107 (3):646–51. doi:10.1002/jbm.b.34157.
  • Farooq, V., B. D. Gogas, and P. W. Serruys. 2011. Restenosis. Circulation. Cardiovascular Interventions 4 (2):195–205. doi:10.1161/CIRCINTERVENTIONS.110.959882.
  • Faxon, D. P., T. A. Sanborn, and C. C. Haudenschild. 1987. Mechanism of angioplasty and its relation to restenosis. The American Journal of Cardiology 60 (3):5B–9B. doi:10.1016/0002-9149(87)90476-0.
  • Forrester, J. S., M. Fishbein, R. Helfant, and J. Fagin. 1991. A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies. Journal of the American College of Cardiology 17 (3):758–69. doi:10.1016/s0735-1097(10)80196-2.
  • Gupta, C., A. Vikram, D. N. Tripathi, P. Ramarao, and G. B. Jena. 2010. Antioxidant and antimutagenic effect of quercetin against DEN induced hepatotoxicity in rat. Phytotherapy Research: PTR 24 (1):119–28. doi:10.1002/ptr.2883.
  • Halder, A., P. Mukherjee, S. Ghosh, S. Mandal, U. Chatterji, and A. Mukherjee. 2018. Smart PLGA nanoparticles loaded with Quercetin: Cellular uptake and in-vitro anticancer study. Materials Today: Proceedings 5 (3, Part 3):9698–705.
  • Hayashi, S-i., A. Yamamoto, F. You, K. Yamashita, Y. Ikegame, M. Tawada, T. Yoshimori, S. Shimizu, and S. Nakashima. 2009. The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. The American Journal of Pathology 175 (5):2226–34. doi:10.2353/ajpath.2009.090152.
  • Huff, M. 2022. Review paper: Residual stresses in deposited thin-film material layers for micro- and nano-systems manufacturing. Micromachines 13 (12):2084. doi:10.3390/mi13122084.
  • Iyer, R., A. E. Kuriakose, S. Yaman, L.-C. Su, D. Shan, J. Yang, J. Liao, L. Tang, S. Banerjee, H. Xu, et al. 2019. Nanoparticle eluting-angioplasty balloons to treat cardiovascular diseases. International Journal of Pharmaceutics 554:212–23. doi:10.1016/j.ijpharm.2018.11.011.
  • Katsanos, K., S. Spiliopoulos, P. Kitrou, M. Krokidis, and D. Karnabatidis. 2019. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. Journal of the American Heart Association 8 (10):e011245. doi:10.1161/JAHA.119.012172.
  • Kaule, S., I. Minrath, F. Stein, U. Kragl, W. Schmidt, K.-P. Schmitz, K. Sternberg, and S. Petersen. 2015. Correlating coating characteristics with the performance of drug-coated balloons–a comparative in vitro investigation of own established hydrogel- and ionic liquid-based coating matrices. PloS One 10 (3):e0116080. doi:10.1371/journal.pone.0116080.
  • Kleinedler, J. J., J. D. Foley, E. A. Orchard, and T. R. Dugas. 2012. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization. Journal of Controlled Release: Official Journal of the Controlled Release Society 159 (1):27–33. doi:10.1016/j.jconrel.2012.01.008.
  • Kong, B., J. H. Seog, L. M. Graham, and S. B. Lee. 2011. Experimental considerations on the cytotoxicity of nanoparticles. Nanomedicine (London, England) 6 (5):929–41. doi:10.2217/nnm.11.77.
  • Labhasetwar, V., C. Song, and R. J. Levy. 1997. Nanoparticle drug delivery system for restenosis. Advanced Drug Delivery Reviews 24 (1):63–85. doi:10.1016/S0169-409X(96)00483-8.
  • Lichtenstein, D., T. Meyer, L. Böhmert, S. Juling, C. Fahrenson, S. Selve, A. Thünemann, J. Meijer, I. Estrela-Lopis, A. Braeuning, et al. 2017. Dosimetric quantification of coating-related uptake of silver nanoparticles. Langmuir: The ACS Journal of Surfaces and Colloids 33 (45):13087–97. doi:10.1021/acs.langmuir.7b01851.
  • Nakazawa, G., A. V. Finn, M. C. John, F. D. Kolodgie, and R. Virmani. 2007. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents. The American Journal of Cardiology 100 (8b):36m–44m. doi:10.1016/j.amjcard.2007.08.020.
  • Olaf, J. R., M. Andrew, and J. S. B. David. 2007. Human serum albumin and quercetin interactions monitored by time-resolved fluorescence: Evidence for enhanced discrete rotamer conformations. Journal of Biomedical Optics 12 (3):034013.
  • Preibisch, S., S. Saalfeld, and P. Tomancak. 2009. Globally optimal stitching of tiled 3D microscopic image acquisitions. Bioinformatics (Oxford, England) 25 (11):1463–5. doi:10.1093/bioinformatics/btp184.
  • Rogers, J. H., and J. R. Laird. 2007. Overview of new technologies for lower extremity revascularization. Circulation 116 (18):2072–85. doi:10.1161/CIRCULATIONAHA.107.715433.
  • Rothman, A., S. B. Perry, J. F. Keane, and J. E. Lock. 1990. Early results and follow-up of balloon angioplasty for branch pulmonary artery stenoses. Journal of the American College of Cardiology 15 (5):1109–17. doi:10.1016/0735-1097(90)90250-s.
  • Salehi, B., L. Machin, L. Monzote, J. Sharifi-Rad, S. M. Ezzat, M. A. Salem, R. M. Merghany, N. M. El Mahdy, C. S. Kılıç, O. Sytar, et al. 2020. Therapeutic potential of quercetin: new insights and perspectives for human health. ACS Omega 5 (20):11849–72. doi:10.1021/acsomega.0c01818.
  • Schneider, C. A., W. S. Rasband, and K. W. Eliceiri. 2012. NIH Image to ImageJ: 25 years of image analysis. Nature Methods 9 (7):671–5. doi:10.1038/nmeth.2089.
  • Secemsky, E. A., and E. J. Armstrong. 2018. Femoropopliteal stent implantation. Circulation. Cardiovascular Interventions 11 (8):e007134. doi:10.1161/CIRCINTERVENTIONS.118.007134.
  • Song, P., Z. Fang, H. Wang, Y. Cai, K. Rahimi, Y. Zhu, F. G. R. Fowkes, F. J. I. Fowkes, and I. Rudan. 2020. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: A systematic review, meta-analysis, and modelling study. The Lancet. Global Health 8 (5):e721–e729. doi:10.1016/S2214-109X(20)30117-0.
  • Teeguarden, J. G., P. M. Hinderliter, G. Orr, B. D. Thrall, and J. G. Pounds. 2007. Particokinetics In vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicological Sciences: An Official Journal of the Society of Toxicology 95 (2):300–12. doi:10.1093/toxsci/kfl165.
  • Tepe, G., J. Laird, P. Schneider, M. Brodmann, P. Krishnan, A. Micari, C. Metzger, D. Scheinert, T. Zeller, D. J. Cohen, et al. 2015. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease. Circulation 131 (5):495–502. doi:10.1161/CIRCULATIONAHA.114.011004.
  • Thukkani, A. K., and S. Kinlay. 2015. Endovascular intervention for peripheral artery disease. Circulation Research 116 (9):1599–613. doi:10.1161/CIRCRESAHA.116.303503.
  • Tyson, R. J., C. C. Park, J. R. Powell, J. H. Patterson, D. Weiner, P. B. Watkins, and D. Gonzalez. 2020. Precision dosing priority criteria: drug, disease, and patient population variables. Frontiers in Pharmacology 11:420. doi:10.3389/fphar.2020.00420.
  • Warner, J. A., B. Forsyth, F. Zhou, J. Myers, C. Frethem, and G. Haugstad. 2016. Characterization of Pebax angioplasty balloon surfaces with AFM, SEM, TEM, and SAXS. Journal of Biomedical Materials Research. Part B, Applied Biomaterials 104 (3):470–5. doi:10.1002/jbm.b.33414.
  • Xie, H., H. Liu, P. Svenmarker, J. Axelsson, C. T. Xu, S. Gräfe, J. H. Lundeman, H. P. Cheng, S. Svanberg, N. Bendsoe, et al. 2011. Drug quantification in turbid media by fluorescence imaging combined with light-absorption correction using white Monte Carlo simulations. Journal of Biomedical Optics 16 (6):066002.
  • Xiong, S., S. George, H. Yu, R. Damoiseaux, B. France, K. W. Ng, and J. S.-C. Loo. 2013. Size influences the cytotoxicity of poly (lactic-co-glycolic acid) (PLGA) and titanium dioxide (TiO2) nanoparticles. Archives of Toxicology 87 (6):1075–86. doi:10.1007/s00204-012-0938-8.
  • Yadav, N., A. K. Tripathi, and A. Parveen. 2022. PLGA-quercetin nano-formulation inhibits cancer progression via mitochondrial dependent caspase-3,7 and independent FoxO1 activation with concomitant PI3K/AKT suppression. Pharmaceutics 14 (7):1326. doi:10.3390/pharmaceutics14071326.
  • Zhang, C., F. Chen, M. H. Gray, R. Tirawat, and R. E. Larsen. 2017. An elasto-plastic solution for channel cracking of brittle coating on polymer substrate. International Journal of Solids and Structures 120:125–36. doi:10.1016/j.ijsolstr.2017.04.033.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.